Elicio Therapeutics Prepares $40 Million IPO Plan
Elicio Therapeutics has filed to raise $40 million in an IPO. The firm is developing treatments for various cancers.
Elicio Therapeutics has filed to raise $40 million in an IPO. The firm is developing treatments for various cancers.
Just Eat Takeaway’s order growth exceeds all expectations. JET is guiding for significantly larger short-term losses.
Tractor Supply (TSCO) is scheduled to announce Q2 earnings results on Monday, July 19th, before market open.The consensus EPS…
Shares of Lovesac (LOVE) have corrected ~30% since the start of June, despite tremendous fundamental performance. See why LOVE…
Welcome to Seeking Alpha’s Catalyst Watch – a breakdown of some of next week’s actionable events that stand out….
Following the June CPI print, value and cyclicals have materially underperformed growth. As energy stocks correct, look for opportunities…
Instructure has filed proposed terms for a $250 million IPO. The firm provides an online e-learning platform for educators…
After the past couple of weeks when the commercial banking system saw reserve balances drop, reserve balances jumped up…
Healthcare Trust of America (HTA) is opportunistically priced with its quality and growth not being reflected in its steeply…
Bitcoin is developing a clear Wyckoff accumulation pattern. Click here to discover what this means for the price of…